Almirall, S.A. (BME:ALM)

Market Cap	2.31B
Revenue (ttm)	1.03B
Net Income (ttm)	24.35M
Shares Out	214.79M
EPS (ttm)	0.11
PE Ratio	94.34
Forward PE	34.86
Dividend	0.18 (1.71%)
Ex-Dividend Date	May 15, 2025

Volume	44,854
Average Volume	119,726
Open	10.78
Previous Close	10.76
Day's Range	10.64 - 10.78
52-Week Range	8.03 - 11.40
Beta	0.30
RSI	49.32
Earnings Date	Jul 25, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ALM